CDC Omits Pull Incentives From Antimicrobial Plan, Disappoints Industry

By Kelly Lienhard / October 15, 2020 at 2:38 PM
An official with the Biotechnology Innovation Organization said he’s disappointed that the federal government failed to discuss pull incentives for antimicrobial medicines in its recently released national plan to reduce antibiotic resistance. Though pull incentives are largely left out of the plan, the official noted he was pleased to see some targets for push incentives, including potential changes to CMS’ add-on payment system. The plan, released by the Centers for Disease Control and Prevention on Friday (Oct. 9), proposes coordinated...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.